418
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Influenza type A virus: an outstandingly protean pathogen and a potent modular weapon

Pages 123-138 | Received 04 Feb 2012, Accepted 07 May 2012, Published online: 13 Jun 2012

References

  • Greninger A. (2004). The Definition and Measurement of Dangerous Research, www.cissm.umd.edu/papers/files/greninger.pdf
  • Altmüller A, Kunerl M, Müller K, Hinshaw VS, Fitch WM, Scholtissek C. (1992). Genetic relatedness of the nucleoprotein (NP) of recent swine, turkey, and human influenza A virus (H1N1) isolates. Virus Res, 22, 79–87.
  • Anchlan D, Ludwig S, Nymadawa P, Mendsaikhan J, Scholtissek C. (1996). Previous H1N1 influenza A viruses circulating in the Mongolian population. Arch Virol, 141, 1553–1569.
  • Beare AS, Webster RG. (1991). Replication of avian influenza viruses in humans. Arch Virol, 119, 37–42.
  • Both GW, Shi CH, Kilbourne ED. (1983). Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication. Proc Natl Acad Sci USA, 80, 6996–7000.
  • Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bresee JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Lu X, Cox NJ, Fukuda K. (2000). Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis, 181, 344–348.
  • Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. (2008). Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol, 167, 775–785.
  • CBS 60 Minutes. Swine Flu. June 19, 2009.
  • Chen PS, Tsai FT, Lin CK, Yang CY, Chan CC, Young CY, Lee CH. (2010). Ambient influenza and avian influenza virus during dust storm days and background days. Environ Health Perspect, 118, 1211–1216.
  • Cohen J. (2012). The Limits of Avian Flu Studies in Ferrets. Science, 335, 512–513.
  • Copeland KM, Elliot AJ, Daniels RS. (2005). Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutinin. J Virol, 79, 6459–6471.
  • Egypt: Qulubiya Governor states AI deliberately spread between poultry farms for compensation Egypt News 2/22/10.
  • Enserink M. (2012). Scientists Brace for Media Storm Around Controversial Flu Studies. Science. http://news.sciencemag.org/scienceinsider/2011/11/scientists-brace-for-media-storm.html. Retrieved 2012-01-23.
  • European labs discover flu vaccines contaminated, March 28, 2009 Flu News Network http://cottontopssandbox.wordpress.com/2009/03/28/european-labs-discover-flu-vaccines-contaminated
  • Flandorfer A, García-Sastre A, Basler CF, Palese P. (2003). Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. J Virol, 77, 9116–9123.
  • Flint M, Thomas JM, Maidens CM, Shotton C, Levy S, Barclay WS, McKeating JA. (1999). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol, 73, 6782–6790.
  • Fouchier RAM, Schneeberger PM, Rozendaal FM, et al. (2004). Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proceedings of the National Academy of Sciences USA, 101, 1356–1361.
  • Gaydos JC, Top FH, Hodder RA, Russell PK. (2006). Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerging Infectious Diseases, 12, 23–28.
  • Ghedin E, Fitch A, Boyne A, Griesemer S, DePasse J, Bera J, Zhang X, Halpin RA, Smit M, Jennings L, St George K, Holmes EC, Spiro DJ. (2009). Mixed infection and the genesis of influenza virus diversity. J Virol, 83, 8832–8841.
  • Gibbs AJ, Armstrong JS, Downie JC. (2009). From where did the 2009 ‘swine-origin’ influenza A virus (H1N1) emerge? Virol J, 6, 207.
  • Gilbert M, Xiao X, Domenech J, Lubroth J, Martin V, Slingenbergh J. (2006). Anatidae migration in the western Palearctic and spread of highly pathogenic avian influenza H5NI virus. Emerging Infect Dis, 12, 1650–1656.
  • Goldfield M, Bartley JD, Pizzuti W, et al. (1977). Influenza in New Jersey in 1976: isolations of influenza A/New Jersey /76 at Fort Dix. J Infectious Diseases, 136, S347–S355.
  • Harmon K. (2011). What Will the Next Influenza Pandemic Look Like?. Scientific American. http://www.scientificamerican.com/article.cfm?id=next-influenza-pandemic. Retrieved 2012-01-23.
  • Harris S. (1991). Japanese biological warfare experiments and other atrocities in Manchuria, 1932–1945, and the subsequent United States cover up: a preliminary assessment, Crime, Law and Social Change, Volume 15, Number 3/1991 http://www.springerlink.com/content/x8k1r31367450677/
  • Hatziioannou T, Valsesia-Wittmann S, Russell SJ, Cosset FL. (1998). Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J Virol, 72, 5313–5317.
  • Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, Rana B, McClelland G, Ipe D, Roberts N, Ward P. (2000). Oral oseltamivir in human experimental influenza B infection. Antivir Ther (Lond), 5, 205–213.
  • Helen B. Canadian intelligence report about the weaponization of bird flu declassified, The Canadian Press, March 8, 2005.
  • How to Deal with Swine Flu: Heeding the Mistakes of 1976, TIME Magazine, Apr. 27, 2009.
  • Hugh-Jones ME, Rosenberg BH, Jacobsen S. (2011). The 2001 anthrax attack: Key observations. Journal of Bioterrorism & Biodefense, Special Issue 3, http://dx.doi.org/10.4172/2157–2526.S3-001
  • Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets, Nature doi:10.1038/nature10831 http://www.nature.com/nature/journal/vaop/ncurrent/full/nature10831.html
  • Influenza Overview — ProMED Summary of Strains, 2004 http://www.medicalecology.org/diseases/influenza/influenza.htm
  • Iran to produce bird flu vaccine, AP. Jan 16, 2008.
  • Jackson BA et al. (2006). Bioterrorism with Zoonotic Disease: Public Health Preparedness Lessons from a Multiagency Exercise, Biosecurity and Bioterrorism: Biodefence Strategy. Practice and Science, 4.
  • Kasel JA, Couch RB. (1969). Experimental infection in man and horses with influenza A viruses. Bull World Health Organ, 41, 447–452.
  • Kendal AP, Noble GR, Dowdle WR. (1977). Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology, 82, 111–121.
  • Khalenkov A, Perk S, Panshin A, Golender N, Webster RG. (2009). Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology, 383, 32–38.
  • Kobasa D, Jones SM, Shinya K, et al. (2007). Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature, 445, 319–323.
  • Koebler J. Universal Flu Vaccine Could Be Available by 2013 U.S. News January 13, 2012.
  • Krug RM. (2003). The potential use of influenza virus as an agent for bioterrorism. Antiviral Res, 57, 147–150.
  • Langley WA et al. (2010). Induction of Neutralizing Antibody Responses to Anthrax Protective Antigen by Using Influenza Virus Vectors: Implications for Disparate Immune System Priming Pathways. Journal of Virology, 84, 8300–8307.
  • Lazarovits J, Naim HY, Rodriguez AC, Wang RH, Fire E, Bird C, Henis YI, Roth MG. (1996). Endocytosis of chimeric influenza virus hemagglutinin proteins that lack a cytoplasmic recognition feature for coated pits. J Cell Biol, 134, 339–348.
  • Lee YJ, Choi YK, Kim YJ, et al. (2008). Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerging Infectious Diseases, 14, 487–490.
  • Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS. (2004). Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature, 430, 209–213.
  • Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. (2009). Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med, 361, 112–115.
  • MacKenzie D., Bioterror fears could block crucial flu research New Scientist, 21 November 2011, http://www.newscientist.com/article/dn21195-bioterror-fears-could-block-crucial-flu-research.html
  • Madjid M, Scott L, Parsa M, Ward C. (2003). Influenza as a bioweapon. J Royal Soc Med, 96, 345–346.
  • Marisa P et al. (2009). Avian influenza vaccination in Egypt: Limitations of the current Strategy. J Mol Genet Med, 3, 198–204.
  • Martin HR, Zambon ACRM, Barclay WS. (2004). Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. J Virol, 78, 502–507.
  • Mitzi B. Grant will fund study of influenza as agent of bioterror, Stanford Report, September 24, 2003.
  • Observer: Bird flu crimes? February 20, 2008.
  • Ogata T, Yamazaki Y, Okabe N, Nakamura Y, Tashiro M, Nagata N, Itamura S, Yasui Y, Nakashima K, Doi M, Izumi Y, Fujieda T, Yamato S, Kawada Y. (2008). Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer. J Epidemiol, 18, 160–166.
  • Oliveira BC, Liberto MI, Barth OM, Cabral MC. (2002). Construction of yellow fever-influenza A chimeric virus particles. J Virol Methods, 106, 185–196.
  • Ozawa Y, Makino S, Park JY, Chang JH, Kim JH, An SH. (2006). A review of recent unexpected animal disease events in Japan and Korea and the follow-up action taken. Rev - Off Int Epizoot, 25, 125–135.
  • Oxford J. (2004). Nature’s biological weapon. Nature, 429, 345–346.
  • Pandemic Influenza Civil-Military Senior Planners Workshop, US-Pacific-Command notification, April 11, 2010 http://us-pacific-command.blogspot.com/2010/04/us-and-laos-co-host-multinational.html
  • Pantin-Jackwood M, Wasilenko JL, Spackman E, Suarez DL, Swayne DE. (2010). Susceptibility of turkeys to pandemic-H1N1 virus by reproductive tract insemination. Virol J, 7, 27.
  • Pattie DC. Avian influenza as a biological weapon: Threat assessment and public health alert, Ph.D. Thesis, 2008, George Mason University, Virginia.
  • Peterson AT, Benz BW, Papes M. (2007). Highly pathogenic H5N1 avian influenza: entry pathways into North America via bird migration. PLoS ONE, 2, e261.
  • Q&A: Siti Fadilah Supari. Nature News. Nature Publishing Group. 2007-12-09. http://www.nature.com/news/2007/071219/full/4501137a.html
  • Racaniello V. (2012). Influenza H5N1 is not lethal in ferrets after airborne transmission. Virology Blog, March 2012 http://www.virology.ws/2012/03/01/influenza-h5n1-is-not-lethal-in-ferrets-after-airborne-transmission/.
  • Reid AH, Fanning TG, Hultin JV, Taubenberger JK. (1999). Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proceedings of the National Academy of Sciences USA, 96, 1651–1656.
  • Reid AH, Fanning TG, Janczewski TA, Taubenberger JK. (2000). Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proceedings of the National Academy of Sciences USA, 97, 6785–6790.
  • Rose E. Labs urged to destroy pandemic flu strain. Associated Press, London, UK, 12 April 2005.
  • Schaffer FL, Soergel ME, Straube DC. (1976). Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids. Arch Virol, 51, 263–273.
  • Schijven FJ, Teunis PFM, Roda Husman AM. Quantitative Risk Assessment of Avian Influenza Virus Infection via Water, 1-Mar-2006, Rijksinstituut voor Volksgezondheid en Milieu RIVM, http://hdl.handle.net/10029/7430
  • Schoch-Spana M. (2000). Implications of pandemic influenza for bioterrorism response. Clin Infect Dis, 31, 1409–1413.
  • Sharshov K, Silko N, Sousloparov I, Zaykovskaya A, Shestopalov A, Drozdov I. (2010). Avian influenza (H5N1) outbreak among wild birds, Russia, 2009. Emerging Infect Dis, 16, 349–351.
  • Shoham D, Wolfson Z. (2004). The Russian biological weapons program: vanished or disappeared?. Crit Rev Microbiol, 30, 241–261.
  • Shoham D. (2005a). Image versus reality of Iranian chemical and biological weapons. International J. of Intelligence and Counterintelligence, 18, 89–141.
  • Shoham D. (2005b). Viral Pathogens of Humans Likely to be Preserved in Natural Ice. In: Life in Ancient Ice. (ed. Castello JD and Rogers SO), Princeton University Press, Princeton, pp. 208–226.
  • Shoham D. (2006). Review: molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain –a conceptual shift. Virus Genes, 33, 127–132.
  • Shoham D, Rogers SO. (2006). Greenland as a plausible springboard for trans-Atlantic avian influenza spread. Med Hypotheses, 67, 1460–1461.
  • Shoham D. (2007a). Bioterrorism. In: Handbook of Pharmaceutical Biotechnology, John Wiley and Sons, Editor-in-Chief: Shayne Gad, pp. 1525–1651.
  • Shoham D. (2007b). How will Iran retaliate to a strike on its nuclear facilities?. Contemporary Security Policy, 28, 542–558.
  • Shoham D, Jacobsen S. (2007). Technical intelligence in retrospect: the 2001 anthrax letters powder. International J. of Intelligence and Counterintelligence, 20, 79–105.
  • Shoham D. (2009). Is there a Critical Mass that would likely trigger the Emergence of a Pandemic Avian Influenza Genotype?. In: Viral Genomes: Diversity, Properties and Parameters Editors: Zhi Feng and Ming Long, Nova Science Publishers, Inc. pp. 123–143.
  • Shoham D. (2011). The Modes of Evolutionary Emergence of Primal and Late Pandemic Influenza Virus Strains from Viral Reservoir in Animals: An Interdisciplinary Analysis, Influenza Research and Treatment, vol. 2011, Article ID 861792, 27 pages. doi:10.1155/2011/861792 Influenza Research and Treatment, http://www.hindawi.com/journals/irt/2011/861792/.
  • Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. (2009). Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 459, 1122–1125.
  • Sorrell EM, Wan H, Araya Y, Song H, Perez DR. (2009). Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci USA, 106, 7565–7570.
  • Srinivasan A, Viswanathan K, Raman R, et al. (2008). Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proceedings of the National Academy of Sciences USA, 105, 2800–2805.
  • Staczek J, Gilleland HE Jr, Gilleland LB, Harty RN, García-Sastre A, Engelhardt OG, Palese P. (1998). A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun, 66, 3990–3994.
  • Stephen E, Gary M, Greg G, Jim G, Mike W. ProPublica, Was the FBI’s Science Good Enough to ID the Anthrax Killer? Scientific American, October 11, 2011 www.scientificamerican.com/article.cfm?id=fbi-science-good-enough-id-anthrax-killer
  • Stewart JJ. (2002). Parameters of Influenza Aerosol Transmission. Comments on Theoretical Biology, 7, 445–457.
  • Symons H. (2002). Report on Royal Society and British Association for the Advancement of Science Meeting on Bioterrorism, December 2001, UK.
  • Tellier R. (2006). Review of aerosol transmission of influenza A virus. Emerging Infect Dis, 12, 1657–1662.
  • The Fourth ESWI http://www.eswiconference.org Influenza Conference 11–14 September 2011 Malta.
  • Thomas G.. (2006). North Korea weaponizing bird flu - Bio-warfare experts call it ‘greatest threat al-Qaida could unleash. Joseph Farah’s G2 Bulletin Top Story, London.
  • Tumpey TM, Maines TR, Van Hoeven N, et al. (2007). A Two-Amino Acid Change in the Hemagglutinin of the 1918 A Influenza Virus Abolishes Transmission. Science, 315, 655–659.
  • Update on Avian Influenza - OIE www.oie.int/.../AVIAN%20INFLUENZA/A_AI-Asia.htm
  • US Department of Homeland Security and Health and Human Services’ pandemic flu web site: www.pandemicflu.gov.
  • Vector Website – http://www.vector.nsc.ru/DesktopDefault.aspx?lcid=9&tabindex=1&tabid=52
  • von Bubnoff A. (2005). Special Report: The 1918 flu virus is resurrected. Nature, 437, 794–795.
  • Vorobev AA. (2001). Evaluation of probability of use of bioagents as biological weapons. Epidemiol. Infektsion Bolez, 6, 54–56.
  • When politics and swine flu infect health, Stephanie Beck, SF Gate, April 30, 2009.
  • WHO concerned that new H5N1 influenza research could undermine the 2011. Pandemic Influenza Preparedness Framework; Statement - 30 December 2011 http://www.who.int/mediacentre/news/statements/2011/pip_framework_20111229/en/index.html
  • WHO Memorandum – Missing samples of deadly flu strain, 19 April 2005.
  • WHO. Inter-country-consultation: influenza A/H5N1 in humans in Asia: Manila, Philippines. http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_7/en/ 2005.
  • Wintemitz MC, Wason IM, McNamara FP. (1920). The Pathology of Influenza. New Haven, CT, Yale University Press.
  • Zimmer SM, Burke DS. (2009). Historical perspective–Emergence of influenza A (H1N1) viruses. N Engl J Med, 361, 279–285.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.